|
SER Serina Therapeutics Inc 1708599 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-6,356,000.00 |
| Balance Sheet |
|
Current Assets
|
$25,030,000.00 |
|
Assets
|
$25,814,000.00 |
|
Current Liabilities
|
$3,762,000.00 |
|
Liabilities
|
$7,084,000.00 |
|
Equity
|
$-37,000.00 |
|
Shares Out
|
25400000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,252,000.00 |
|
Investing Cash Flow
|
$-53,000.00 |
| Market Analysis |
Market Cap
|
$67,310,000.00 |
|
Price
|
$2.65 |
|
PB
|
0.11 |
|
EPS
|
-0.55 |
|
PS
|
217.75 |
|
FCF
|
$-11,274,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SER documents filed with the SEC.
SER Filings
Clear
